Enrichment of regulatory T cells in invasive breast tumor correlates with the upregulation of IL-17A expression and invasiveness of the tumor

European Journal of Immunology

Volumn 43, Issue 6, 2013, Pages 1518-1528

  Benevides, Luciana ^a   Cardoso, Cristina R B ^a   Tiezzi, Daniel G ^a   Marana, Heitor R C ^a   Andrade, Jurandyr M ^a   Silva, João S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Breast tumor; IL 17; Immunosuppression; Regulatory T (Treg) cells

Indexed keywords

ANGIOGENIC FACTOR; CD103 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR6; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GELATINASE A; GELATINASE B; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INTERLEUKIN 17; INTERLEUKIN 8; MACROPHAGE DERIVED CHEMOKINE; MESSENGER RNA; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; VASCULOTROPIN;

ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CANCER PROGNOSIS; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; INFLAMMATORY INFILTRATE; LYMPHOCYTE PROLIFERATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TH17 CELL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR INVASION; TUMOR MICROENVIRONMENT; UPREGULATION;

ANTIGENS, CD; BREAST NEOPLASMS; CARCINOMA, DUCTAL; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CHEMOKINE CCL22; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GLUCOCORTICOID-INDUCED TNFR-RELATED PROTEIN; HUMANS; INTERLEUKIN-17; NEOPLASM INVASIVENESS; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; RECEPTORS, CCR6; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 84879466032     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201242951     Document Type: Article

References (45)

1. Whiteside, T. L., The tumor microenvironment and its role in promoting tumor growth. Oncogene 2008. 27: 5904-5912.
2. Fontenot, J. D., Gavin, M. A. and Rudensky, A. Y., Foxp3 programs the development and function of CD4+CD25 +regulatory T cells. Nat. Immunol. 2003. 4: 330-336.
3. Strauss, L., Bergmann, C., Szczepanski, M., Gooding, W., Johnson, J. T. and Whiteside, T. L., A unique subset of CD4+CD25highFoxp3 +T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment. Clin. Cancer Res. 2007. 13: 4345-4354.
4. Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M. et al., Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 2004. 10: 942-949.
5. Gao, Q., Qiu, S. J., Fan, J., Zhou, J., Wang, X. Y., Xiao, Y. S., Xu, Y. et al., Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J. Clin. Oncol. 2007. 25: 2586-2593.
6. Mizukami, Y., Kono, K., Kawaguchi, Y., Akaike, H., Kamimura, K., Sugai, H. and Fujii, H., Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer. Br. J. Cancer 2008. 98: 148-153.
7. Badoual, C., Hans, S., Rodriguez, J., Peyrard, S., Klein, C., Agueznay Nel, H., Mosseri, V. et al., Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers. Clin. Cancer Res. 2006. 12: 465-472.
8. Tzankov, A., Meier, C., Hirschmann, P., Went, P., Pileri, S. A. and Dirnhofer, S., Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma. Haematologica 2008. 93: 193-200.
9. Menetrier-Caux, C., Gobert, M. and Caux, C., Differences in tumor regulatory T-cell localization and activation status impact patient outcome. Cancer Res. 2009. 69: 7895-7898.
10. Grabenbauer, G. G., Lahmer, G., Distel, L. and Niedobitek, G., Tumor-infiltrating cytotoxic T cells but not regulatory T cells predict outcome in anal squamous cell carcinoma. Clin. Cancer Res. 2006. 12: 3355-3360.
11. Ciree, A., Michel, L., Camilleri-Broet, S., Jean Louis, F., Oster, M., Flageul, B., Senet, P. et al., Expression and activity of IL-17 in cutaneous T-cell lymphomas (mycosis fungoides and Sezary syndrome). Int. J. Cancer 2004. 112: 113-120.
12. Kato, T., Furumoto, H., Ogura, T., Onishi, Y., Irahara, M., Yamano, S., Kamada, M. et al., Expression of IL-17 mRNA in ovarian cancer. Biochem. Biophys. Res. Commun. 2001. 282: 735-738.
13. Annunziato, F., Cosmi, L., Santarlasci, V., Maggi, L., Liotta, F., Mazzinghi, B., Parente, E. et al., Phenotypic and functional features of human Th17 cells. J. Exp. Med. 2007. 204: 1849-1861.
14. Numasaki, M., Fukushi, J., Ono, M., Narula, S. K., Zavodny, P. J., Kudo, T., Robbins, P. D. et al., Interleukin-17 promotes angiogenesis and tumor growth. Blood 2003. 101: 2620-2627.
15. Nishikawa, H. and Sakaguchi, S., Regulatory T cells in tumor immunity. Int. J. Cancer 2010. 127: 759-767.
16. Allan, S. E., Crome, S. Q., Crellin, N. K., Passerini, L., Steiner, T. S., Bacchetta, R., Roncarolo, M. G. et al., Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int. Immunol. 2007. 19: 345-354.
17. Roncarolo, M. G. and Gregori, S., Is FOXP3 a bona fide marker for human regulatory T cells? Eur. J. Immunol. 2008. 38: 925-927.
18. Hori, S., Nomura, T. and Sakaguchi, S., Control of regulatory T cell development by the transcription factor Foxp3. Science 2003. 299: 1057-1061.
19. Gavin, M. A., Rasmussen, J. P., Fontenot, J. D., Vasta, V., Manganiello, V. C., Beavo, J. A. and Rudensky, A. Y., Foxp3-dependent programme of regulatory T-cell differentiation. Nature 2007. 445: 771-775.
20. Huehn, J., Siegmund, K., Lehmann, J. C., Siewert, C., Haubold, U., Feuerer, M., Debes, G. F. et al., Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J. Exp. Med. 2004. 199: 303-313.
21. Yagi, H., Nomura, T., Nakamura, K., Yamazaki, S., Kitawaki, T., Hori, S., Maeda, M. et al., Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int. Immunol. 2004. 16: 1643-1656.
22. Gobert, M., Treilleux, I., Bendriss-Vermare, N., Bachelot, T., Goddard-Leon, S., Arfi, V., Biota, C. et al., Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. Cancer Res. 2009. 69: 2000-2009.
23. Oo, Y. H., Weston, C. J., Lalor, P. F., Curbishley, S. M., Withers, D. R., Reynolds, G. M., Shetty, S. et al., Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver. J. Immunol. 2010. 184: 2886-2898.
24. Suffia, I., Reckling, S. K., Salay, G. and Belkaid, Y., A role for CD103 in the retention of CD4+CD25+ Treg and control of Leishmania major infection. J. Immunol. 2005. 174: 5444-5455.
25. Zou, W., Regulatory T cells, tumour immunity and immunotherapy. Nat. Rev. Immunol. 2006. 6: 295-307.
26. Flavell, R. A., Sanjabi, S., Wrzesinski, S. H. and Licona-Limon, P., The polarization of immune cells in the tumour environment by TGFbeta. Nat. Rev. Immunol. 2010. 10: 554-567.
27. Schmetterer, K. G., Neunkirchner, A. and Pickl, W. F., Naturally occurring regulatory T cells: markers, mechanisms, and manipulation. FASEB J. 2012. 26: 2253-2276.
28. Mitra, R. S., Judge, T. A., Nestle, F. O., Turka, L. A. and Nickoloff, B. J., Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7-1 (CD80) and B7-2 (CD86) expression. J. Immunol. 1995. 154: 2668-2677.
29. Nicolini, A., Carpi, A. and Rossi, G., Cytokines in breast cancer. Cytokine Growth Factor Rev. 2006. 17: 325-337.
30. Faget, J., Biota, C., Bachelot, T., Gobert, M., Treilleux, I., Goutagny, N., Durand, I. et al., Early detection of tumor cells by innate immune cells leads to T(reg) recruitment through CCL22 production by tumor cells. Cancer Res. 2011. 71: 6143-6152.
31. Acosta-Rodriguez, E. V., Napolitani, G., Lanzavecchia, A. and Sallusto, F., Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 2007. 8: 942-949.
32. Murugaiyan, G. and Saha, B., Protumor vs antitumor functions of IL-17. J. Immunol. 2009. 183: 4169-4175.
33. O'Shea, J. J. and Paul, W. E., Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 2010. 327: 1098-1102.
34. Zhou, L., Lopes, J. E., Chong, M. M., Ivanov, II, Min, R., Victora, G. D., Shen, Y. et al., TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008. 453: 236-240.
35. Chen, Y., Haines, C. J., Gutcher, I., Hochweller, K., Blumenschein, W. M., McClanahan, T., Hammerling, G. et al., Foxp3(+) regulatory T cells promote T helper 17 cell development in vivo through regulation of interleukin-2. Immunity 2011. 34: 409-421.
36. Pandiyan, P., Zheng, L., Ishihara, S., Reed, J. and Lenardo, M. J., CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat. Immunol. 2007. 8: 1353-1362.
37. Tosolini, M., Kirilovsky, A., Mlecnik, B., Fredriksen, T., Mauger, S., Bindea, G., Berger, A. et al., Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Res. 2011. 71: 1263-1271.
38. Ladoire, S., Martin, F. and Ghiringhelli, F., Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer. Cancer Immunol. Immunother. 2011. 60: 909-918.
39. Kryczek, I., Banerjee, M., Cheng, P., Vatan, L., Szeliga, W., Wei, S., Huang, E. et al., Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 2009. 114: 1141-1149.
40. Rogers, T. L. and Holen, I., Tumour macrophages as potential targets of bisphosphonates. J. Transl. Med. 2011. 9: 177.
41. Takahashi, H., Numasaki, M., Lotze, M. T. and Sasaki, H., Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells. Immunol. Lett. 2005. 98: 189-193.
42. Kehlen, A., Thiele, K., Riemann, D., Rainov, N. and Langner, J., Interleukin-17 stimulates the expression of IkappaB alpha mRNA and the secretion of IL-6 and IL-8 in glioblastoma cell lines. J. Neuroimmunol. 1999. 101: 1-6.
43. Eikawa, S., Ohue, Y., Kitaoka, K., Aji, T., Uenaka, A., Oka, M. and Nakayama, E., Enrichment of Foxp3+ CD4 regulatory T cells in migrated T cells to IL-6- and IL-8-expressing tumors through predominant induction of CXCR1 by IL-6. J. Immunol. 2010. 185: 6734-6740.
44. Waugh, D. J. and Wilson, C., The interleukin-8 pathway in cancer. Clin. Cancer Res. 2008. 14: 6735-6741.
45. Ghosh, S., Basu, M. and Roy, S. S., ETS-1 regulates vascular endothelial growth factor-induced matrix metalloproteinase-9 and matrix metalloproteinase-13 expression in human ovarian carcinoma cell SKOV-3. J. Biol. Chem. 2012. 287: 15001-15015.